POS-112 EFFECT OF AVACOPAN, A SELECTIVE C5A RECEPTOR INHIBITOR, ON COMPLEMENT 3 GLOMERULOPATHY HISTOLOGIC INDEX OF DISEASE CHRONICITY

Bomback, A., Herlitz, L. C., Yue, H., Kedia, P. P., Schall, T. J., & Bekker, P. (2022). POS-112 EFFECT OF AVACOPAN, A SELECTIVE C5A RECEPTOR INHIBITOR, ON COMPLEMENT 3 GLOMERULOPATHY HISTOLOGIC INDEX OF DISEASE CHRONICITY. Kidney International Reports, 7(2), S47–S48. https://doi.org/10.1016/j.ekir.2022.01.124

Authors:

Andrew S. Bomback

Leal C. Herlitz

H. Yue

P.P. Kedia

Thomas J. Schall

Pirow Bekker

Affiliated Authors:

Andrew S. Bomback

Columbia Affiliation: